Showing results (1-10 of 572) with videos related to

Sort By:
Pageof 58
Critical Reviews in Oncology/Hematology|November 27, 2012
Combination of vascular disrupting agents and ionizing radiationCéline Clémenson, Cyrus Chargari, Eric Deutsch
Acta Oncologica (Stockholm, Sweden)|August 25, 2017
Neutrophils, a candidate biomarker and target for radiation therapy?Antoine Schernberg, Pierre Blanchard, Cyrus Chargari, et al.
The Lancet. Oncology|August 1, 2019
Optimising efficacy and reducing toxicity of anticancer radioimmunotherapyEric Deutsch, Cyrus Chargari, Lorenzo Galluzzi, et al.
Critical Reviews in Oncology/Hematology|December 2, 2008
Concomitant chemo-radiotherapy in clinical trials: to promote step by step rational developmentNicolas Magné, Cyrus Chargari, Jean-Charles Soria, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 26, 2013
Understanding the functions of tumor stroma in resistance to ionizing radiation: emerging targets for pharmacological modulationCyrus Chargari, Céline Clemenson, Isabelle Martins, et al.
Presse Medicale (Paris, France : 1983)|August 27, 2013
Complications of thoracic radiotherapyCyrus Chargari, François Riet, Marianne Mazevet, et al.
International Review of Cell and Molecular Biology|March 30, 2023
Impact of radiation therapy on healthy tissuesCyrus Chargari, Elie Rassy, Carole Helissey, et al.
Critical Reviews in Oncology/Hematology|October 6, 2012
Radiation therapy and immunotherapy: implications for a combined cancer treatmentAntonin Levy, Cyrus Chargari, Morgane Cheminant, et al.
European Journal of Cancer (Oxford, England : 1990)|May 21, 2016
Can immunostimulatory agents enhance the abscopal effect of radiotherapy?Antonin Levy, Cyrus Chargari, Aurelien Marabelle, et al.
Investigational New Drugs|January 17, 2012
Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapyCéline Clémenson, Cyrus Chargari, Laurent Désiré, et al.
Pageof 58